The distribution and gender difference of CYP3A activity in Chinese subjects.
about
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sexEffect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot studyEvaluation of a sex-based difference in the pharmacokinetics of digoxin.Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.Gender: a possible determinant in dosing of dermatologic drugs--an overview.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Sex-specific differences in CYP450 isoforms in humans.Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs.Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.Factors affecting the development of adverse drug reactions (Review article)Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.Effect of danshen extract on the activity of CYP3A4 in healthy volunteers.CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11.Interindividual and intraindividual variability of the urinary 6beta-Hydroxycortisol/Cortisol ratio in Chinese subjects: implications of its use for evaluating CYP3A activity.Cytochrome P4503A activity affects the gender difference in the development of steroid-induced osteonecrosis in rabbits.Prediction of fraction metabolized via CYP3A in humans utilizing cryopreserved human hepatocytes from a set of 12 single donors.Age-related Differences in CYP3A Abundance and Activity in the Liver of the Göttingen Minipig.Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers.Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects.Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population.Extrahepatic cytochrome P450s play an insignificant role in triptolide-induced toxicity.Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjectsA GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
P2860
Q33683890-11F641F6-11A3-4A2A-B6B5-6F736C7F3CD9Q35827661-CCA0C774-EA37-498D-AFF7-3B6C887A1BACQ35827669-0CED9A5D-77FD-4F83-AB13-2445B160A5D0Q36410175-BE019A50-DD45-4BE3-B833-7F98FDF8CBD5Q36440873-CCC9D88D-741F-4CB2-9599-8DD6C83D3790Q36546272-74C58A4C-0470-49E2-803C-22C6B8BD64B8Q36596188-58921865-B74F-4FEC-9B58-890F4C1474D6Q36603317-EB5F29DC-35C8-4EFF-B170-66928CC68D28Q37181876-65269EAD-8D0D-440A-AA62-9267A8162CC5Q37256195-5AC302CF-5138-48FE-94AF-2E489061D1DEQ37359687-C336B61D-9C98-4797-B08E-87B50024DD2CQ37369341-EF5EEE28-1BDB-47A9-9008-CA4CE7664859Q37631543-EF204569-E685-49D1-A32A-8F00B35D6F07Q39944445-D910769A-FE8E-414F-8BAC-3D08FA1477BDQ40985793-61B57D6E-5A7F-4449-956E-9E62B1D37193Q44760621-A27C253C-46D2-4764-96DF-E86260F49F40Q45151697-32FE8256-40A1-4C8F-BBB8-F31DA5C4EBB0Q46302784-1B4C2D21-DC83-43BD-B15B-66D0D96FE314Q47943718-34C24219-450C-4BBC-97E9-56B86BA05EB2Q49145213-12649FC0-42A2-4CC0-8568-6F28C1889EA9Q50550472-06FDE99F-AF73-40DC-AE86-51D22336A2EEQ50667755-2B544637-5ED4-424B-A9E0-F5EF4D37EA0CQ51415497-23F39FC5-86B2-4F28-8CE2-250E3BE9A077Q54580627-391E4BCD-5705-4A10-AE6D-B2A9B1C1C8C1Q55281935-6ACA1B82-8431-4EC2-8952-68883570C6AFQ57500309-03AF0953-1159-445A-82B3-11CEF88F537BQ58294605-244492A4-2790-462F-8CE5-97BCA9BEC5B7
P2860
The distribution and gender difference of CYP3A activity in Chinese subjects.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The distribution and gender difference of CYP3A activity in Chinese subjects.
@ast
The distribution and gender difference of CYP3A activity in Chinese subjects.
@en
type
label
The distribution and gender difference of CYP3A activity in Chinese subjects.
@ast
The distribution and gender difference of CYP3A activity in Chinese subjects.
@en
prefLabel
The distribution and gender difference of CYP3A activity in Chinese subjects.
@ast
The distribution and gender difference of CYP3A activity in Chinese subjects.
@en
P2093
P2860
P1476
The distribution and gender difference of CYP3A activity in Chinese subjects.
@en
P2093
Dong-Sheng Ou-Yang
Guo-Lin Chen
Hong-Hao Zhou
Lian-Sheng Wang
Song-Lin Huang
Xiao-Ping Chen
Zhi-Rong Tan
P2860
P304
P356
10.1046/J.1365-2125.2003.01728.X
P407
P577
2003-03-01T00:00:00Z